A U.S. - India Initiative: Rescuing and Repurposing
of Drugs for Cancer
Bethesda North Marriott Hotel · Bethesda, Maryland U.S.A.
As the burden of cancer continues to escalate across the globe it is of paramount importance that efforts are not limited to finding novel chemical entities which require inordinate financial resources. Another approach being proposed is to “repurpose” FDA-approved drug agents. On Friday May 9, the Accelerating Anticancer Agent Development and Validation Workshop will offer a satellite symposium on Rescuing and Repurposing of Drugs for Cancer. This symposium will provide a road map from rediscovering of drug candidates to their commercialization. This is of particular importance to scientists from large pharmaceutical companies to generic houses in India. In fact, this represents a new “frontier” for business opportunity especially for the pharmaceutical industry in India. This opportunity to partner with the USFDA represents the ability to benefit Indian society by creating a bridge to highly effective examples of new drug development that is an international standard, and balances scientific and commercial prospects with the social good and needs of patients.
Topics that will be discussed include:
- Insight into Oncogenic Pathways: An Opportunity for Drug Repurposing
- IP Issues
- Registration Clinical Trials
- NDA Requirements
- A Business Model for Commercialization
While there is no additional cost to attend, advance sign-up is required to attend the Symposium. Check this option in the on-line registration for the AAADV Workshop.
Sponsors of the RRDC Symposium
Association of Biotechnology Enterprises (ABLE): ABLE is a national forum that represents the Indian biotechnology sector. Launched in April 2003, the primary objective of ABLE is to accelerate the pace of growth of the biotechnology industry in India, through encouraging greater investment in the sector, providing a platform for domestic and overseas companies to explore collaborations and partnerships, partnering with the Government of India in their biotechnology endeavors and forging stronger links between academia and industry. http://ableindia.in/
Open Health Systems Laboratory (OHSL): OHSL was conceived to focus on building global team science consortia by leveraging the best biomedical informatics, information and communication technology to address the key questions of medical science and to provide a quicker and better global public health response. OHSL and its strategic partners undertake projects in life sciences, which are innovative, path breaking, and proof-of-concepts requiring cross-sector collaboration. OHSL was conceived with a focus on team science, leveraging biomedical informatics and information technology for quicker and better global health response. http://www.ohsl.us/